Drug recall D-1354-2022
Product
Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01
Reason for recall
cGMP Deviations: deviations leading to potential cross-contamination.
Lots and codes
Lot#: 023011 Exp 8/31/2022
Recall details
- Recalling firm
- Nephron Sc Inc, West Columbia, SC
- Quantity
- 5040 vials
- Distribution
- USA Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 10, 2022
- Terminated
- September 24, 2024
Related products
- Ketorolac Tromethamine – drug information
- NDC 0487-6232 Ketorolac Tromethamine · Ketorolac Tromethamine 30 mg/mL · Nephron Pharmaceuticals Corporation